Reply
Jasmohan S. Bajaj, Huiping Zhou, Dae Joong Kang, Phillip B. Hylemon – 23 June 2015
Polymorphisms in melanoma differentiation‐associated gene 5 are not associated with clearance of hepatitis C virus in a European American population
Candelaria Vergara, Chloe L. Thio, David Thomas, Priya Duggal – 23 June 2015
Reply
Franziska Hoffmann, Stefan Endres, Simon Rothenfusser – 23 June 2015
Reply
Eriks Smagris, Soumik BasuRay, Jesper Gromada, Jonathan C. Cohen, Helen H. Hobbs – 23 June 2015
The devil's triangle of steatosis, obesity, and liver stiffness
Horia Stefanescu, Monica Lupsor‐Platon, Radu I. Badea – 19 June 2015
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma
Ju Dong Yang, Michael B. Campion, Minetta C. Liu, Roongruedee Chaiteerakij, Nasra H. Giama, Hager Ahmed Mohammed, Xiaodan Zhang, Chunling Hu, Victoria L. Campion, Jin Jen, Sudhakar K. Venkatesh, Kevin C. Halling, Benjamin R. Kipp, Lewis R. Roberts – 19 June 2015 – Circulating tumor cells (CTCs) in blood are associated with poor survival of patients with breast, prostate, or colon cancer. We hypothesized that CTCs are associated with poor survival of patients with cholangiocarcinoma (CCA).
Reply
Salvatore Petta, Antonio Craxì – 19 June 2015
Tenofovir for Hepatitis Delta
Vincent Soriano, Pablo Barreiro, Carmen de Mendoza – 19 June 2015
Potential mechanism underlying the PNPLA3I148M‐Hepatic steatosis connection
Jiang Wei Wu, Hao Yang, Grant A Mitchell – 19 June 2015
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma
Ju Dong Yang, Michael B. Campion, Minetta C. Liu, Roongruedee Chaiteerakij, Nasra H. Giama, Hager Ahmed Mohammed, Xiaodan Zhang, Chunling Hu, Victoria L. Campion, Jin Jen, Sudhakar K. Venkatesh, Kevin C. Halling, Benjamin R. Kipp, Lewis R. Roberts – 19 June 2015 – Circulating tumor cells (CTCs) in blood are associated with poor survival of patients with breast, prostate, or colon cancer. We hypothesized that CTCs are associated with poor survival of patients with cholangiocarcinoma (CCA).